Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 4 3Phase NA 2Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 1Mycoses 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia 1Bone Marrow Failure Disorders 1

Interventions

Cytarabine 147Azacitidine 100venetoclax 95Cyclophosphamide 70fludarabine 69Decitabine 63fludarabine phosphate 55Specimen Handling 37Filgrastim 35Daunorubicin 35Mitoxantrone 30Idarubicin 29Etoposide 27Biopsy 26Injections 25Granulocyte Colony-Stimulating Factor 25Busulfan 22Tacrolimus 21Clofarabine 21Mycophenolic Acid 18Melphalan 18Methotrexate 17Bortezomib 17Whole-Body Irradiation 16Stem Cell Transplantation 16Peripheral Blood Stem Cell Transplantation 16Vorinostat 15Gemtuzumab 15Lenalidomide 14decitabine and cedazuridine drug combination 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Myeloid, Acute × posaconazole × Clear all
NCT02203773 2023-05-16

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

AbbVie

Phase 1 Terminated
212 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡